BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-192@pharmaconomics
DTSTAMP:20260707T003509Z
DTSTART;VALUE=DATE:20261017
DTEND;VALUE=DATE:20261018
SUMMARY:IRD PDUFA — Phentolamine Ophthalmic Solution 0.75%
DESCRIPTION:The FDA's approval decision on Phentolamine Ophthalmic Solution 0.75% for presbyopia is due Oct 17\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1228627/000114036126008621/ef20067388_ex99-1.htm\n\nTrack it: https://pharmaconomics.com/e/192
URL:https://pharmaconomics.com/e/192
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:IRD catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR